Given the pharmacologic accessibility of γS, with prior evaluation of GSIs and GSMs for Alzheimer’s Disease and cancer, we present these data to encourage further exploration into this novel biology for application to COVID-19 or to other pathology attributable to the myriad functions ascribed to ACE2. The gene discussed is ACE2; the disease is cancer.